EarningsSQURPHARMA
SQURPHARMA Earnings Update
Announcement summary
- What happened
- SQURPHARMA published a corporate disclosure on 2 May 2017. Read the full announcement for details.
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
(Q3 Un-audited): Consolidated EPS was Tk. 4.27 for January-March 2017 as against Tk. 3.64 for January-March 2016; Consolidated EPS was Tk. 11.39 for July 2016-March 2017 as against Tk. 9.74 for July'15-March'16. Consolidated NOCFPS was Tk. 12.35 for July 2016-March 2017 as against Tk. 12.08 for July 2015-March 2016. Consolidated NAV per share was Tk. 67.51 as of March 31, 2017 and Tk. 59.13 as of June 30, 2016.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616acf0d5a6b00004005f7a6
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.